… and natural history of the disease throughout life. This … development of disease as well as
affect outcomes. Identification of environmental influences could lead to pathways for disease …

… We aimed to develop a set of process and outcome QIs for Crohn’s disease and ulcerative
colitis using standardized, validated methodology that incorporates both content validity (…

… Efforts to slow or prevent the progressive course of inflammatory bowel diseases [IBD] include
early and intensive monitoring and treatment of patients at higher risk for complications. It …

… Crohn’s disease and ulcerative colitis are chronic inflammatory bowel diseases that often
involve organs other than those of the gastrointestinal tract. Immune-related extraintestinal …

… bowel diseases are shifting from simple control of symptoms toward full control of these
diseases … of blocking their progression and preventing bowel damage and disability. New goals …

… involves measuring outcomes that matter most to patients. Our aim was to develop a minimum
Standard Set of patient-centred outcome measures for inflammatory bowel disease [IBD], …

… This analysis may improve internal validity due to the reduced proportion with inflammatory
bowel disease drugs or inflammatory bowel disease surgery observed in older age bands. …

… Treatment goals in inflammatory bowel diseases are evolving beyond the control of symptoms
… and challenges in adopting a treat-to-target approach in inflammatory bowel diseases. …

… (PROs) and objective measures of disease, such as findings from endoscopy. PROs will …
of inflammatory bowel disease (IBD) and for labeling specific drugs for this disease. PROs …

… a population-based European cohort of inflammatory bowel disease (IBD) patients and to
present the first results in terms of clinical outcome parameters and risk factors. Materials and …